🇺🇸 FDA

P1 · Therapeutic area intelligence

Oncology patent intelligence

Anticancer agents, immuno-oncology, ADC, and oncology patent filings — grants, expirations, and assignee activity.

Patents
1,930

Quick answer

1,930 US pharmaceutical patents in our index match Oncology title keywords (A61K/A61P). Cross-link to related drug therapeutic-area hubs and company patent portfolios for full IP context.

  1. US 6929910

    Diagnostic and therapeutic methods using the H37 tumor suppressor gene

    The Regents of the University of California · Granted Tue Aug 16 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  2. US 6924095

    Retrovirus isolated from mantle histiocytes in mantle cell lymphoma

    The Regents of the University of California · Granted Tue Aug 02 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  3. US 6921765

    1-Azabicyclo[2.2.2]octan-3-one derivatives and maleimide derivatives and their use for treating cancer tumors

    APREA AB · Granted Tue Jul 26 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  4. US 6919425

    Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery

    The Board of Regents of the University of Texas System · Granted Tue Jul 19 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  5. US 6911471

    S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer

    The Board of Regents of the University of Texas System · Granted Tue Jun 28 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  6. US 6908918

    Antitumor agents

    The Regents of the University of California · Granted Tue Jun 21 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  7. US 6897018

    DLC-1 gene deleted in cancers

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 24 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  8. US 6897316

    Substituted 2-phenyl-4-quinolone-3-carboxylic acid compounds and their use as antitumor agents

    China Medical University · Granted Tue May 24 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  9. US 6894026

    Long-acting oxytocin analogues for the treatment and prevention of breast cancer and psychiatric disorders

    Atossa Healthcare, Inc. · Granted Tue May 17 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  10. US 6890917

    Geldanamycin derivative and method of treating cancer using same

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 10 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  11. US 6884414

    Recombinant influenza viruses expressing tumor-associated antigens as antitumor agents

    The United State of America as represented by the Department of Health and Human Services · Granted Tue Apr 26 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  12. US 6881420

    Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment that use it to inhibit cancer cell proliferation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Apr 19 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  13. US 6869924

    Human derived monocyte attracting purified protein product useful in a method of treating infection and neoplasms in a human body, and the cloning of full length cDNA thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 22 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  14. US 6869604

    Recombinant anti-tumor RNAse

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Mar 22 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  15. US 6864066

    Epithelial protein lost in neoplasm (EPLIN)

    The Regents of the University of California · Granted Tue Mar 08 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  16. US 6863887

    Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis

    Northwest Biotherapeutics, Inc. · Granted Tue Mar 08 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  17. US 6855696

    Antitumor agents

    The Regents of the University of California · Granted Tue Feb 15 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  18. US 6849417

    Mammalian selenoprotein differentially expressed in tumor cells

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 01 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  19. US 6838081

    Methods for enhancing antigen-presenting cells and anti-tumor responses in a human patient

    The Regents of the University of California · Granted Tue Jan 04 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  20. US 6828471

    Mice models of human prostate cancer

    The Regents of the University of California · Granted Tue Dec 07 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  21. US 6825186

    Method and compositions for treating atheroma, tumors and other neoplastic tissue

    The Board of Regents of the University of Texas System · Granted Tue Nov 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  22. US 6821522

    Tumor Therapy

    The Regents of the University of California · Granted Tue Nov 23 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 18 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  23. US 6818213

    Cancer treatment compositions comprising therapeutic conjugates that bind to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Tue Nov 16 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  24. US 6818749

    Variants of humanized anti carcinoma monoclonal antibody cc49

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 16 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  25. US 6815574

    Methods of simulating human prostate cancer progression

    The Regents of the University of California · Granted Tue Nov 09 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  26. US 6806363

    Cobalamin conjugates useful as antitumor agents

    Minnesota, Regents of the University · Granted Tue Oct 19 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  27. US 6806354

    Methods and compositions for inducing autoimmunity in the treatment of cancers

    The Board of Regents of the University of Texas System · Granted Tue Oct 19 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  28. US 6803386

    Prostacyclin derivative containing compositions and methods of using the same for the treatment of cancer

    United Therapeutics Corporation · Granted Tue Oct 12 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  29. US 6797721

    Phorboxazole derivatives for treating cancer

    Regents of the University of Minnesota · Granted Tue Sep 28 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  30. US 6794188

    Retrovirus vectors derived from avian sarcoma leukosis viruses permitting transfer of genes into mammalian cells and therapeutic uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 21 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  31. US 6783760

    Combined cancer treatment methods using therapeutic conjugates that bind to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Tue Aug 31 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  32. US 6780586

    Methods of diagnosing breast cancer

    Protein Design Labs, Inc. · Granted Tue Aug 24 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  33. US 6780995

    Activated iododerivatives for the treatment of cancer and aids

    Isotechnika, Inc. · Granted Tue Aug 24 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  34. US 6780984

    Method for prognosing cancer and the proteins involved

    Northwestern University · Granted Tue Aug 24 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  35. US 6762020

    Methods of diagnosing breast cancer

    Protein Design Labs, Inc. · Granted Tue Jul 13 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  36. US 6756399

    Use of lipoxygenase inhibitors and PPAR ligands as anti-cancer therapeutic and intervention agents

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 29 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  37. US 6756036

    Methods for treating cancer using PSCA antibodies and fragments thereof

    The Regents of the University of California · Granted Tue Jun 29 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  38. US 6749853

    Combined methods and compositions for coagulation and tumor treatment

    The Board of Regents of the University of Texas System · Granted Tue Jun 15 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  39. US 6737251

    Nucleotide and deduced amino acid sequences of tumor gene Int6

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 18 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  40. US 6723338

    Compositions and methods for treating lymphoma

    The Board of Regents of the University of Texas System · Granted Tue Apr 20 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  41. US 6717017

    Total synthesis of antitumor acylfulvenes

    The Regents of the University of California · Granted Tue Apr 06 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  42. US 6703050

    Methods and compositions for the prevention or treatment of cancer

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Mar 09 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  43. US 6699842

    Dominant negative deletion mutants of C-jun and their use in the prevention and treatment of cancer

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 02 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  44. US 6689362

    Method for treating T-lineage leukemias and lymphomas using a CD7-specific monoclonal antibody (TXU-7) linked to the pokeweed antiviral protein (PAP)

    Regents of the University of Minnesota · Granted Tue Feb 10 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  45. US 6689561

    Tumor suppressor gene and methods for detection of cancer, monitoring of tumor progression and cancer treatment

    The Regents of the University of California · Granted Tue Feb 10 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  46. US 6682890

    Methods of diagnosing and determining prognosis of colorectal cancer

    Protein Design Labs, Inc. · Granted Tue Jan 27 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  47. US 6680171

    I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1 and CD-95 induced apoptosis

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 20 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  48. US 6680196

    Gene that is amplified and overexpressed in cancer and methods of use thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Jan 20 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many Oncology patents are indexed?

1,930 patents match our Oncology classifier (title keywords in USPTO records).

Is this legal or medical advice?

No — patent intelligence is for professional reference. Verify expiration and FTO with qualified patent counsel and primary USPTO records.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.